title: RNA interference-based strategies for metabolic syndrome treatment.
abstract: RNA interference is a naturally occurring cellular mechanism to inhibit the expression of specific gene products. The technical application of RNA interference offers great potential for the specific treatment of a huge variety of diseases including the metabolic syndrome, one of the most challenging threats to human health associated with our civilization. In order to develop novel and powerful strategies for the treatment of the metabolic syndrome, it is essential to define a set of specific gene products that may be targeted by RNA interference. Based on currently available in vitro and in vivo data, we discuss the feasibility of candidate genes involved in the pathophysiology of the metabolic syndrome as potential targets for a rational RNA interference based therapy in this review.
authors.affiliation: Department of Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Moorenstrasse 5, 40225 Duesseldorf, Germany. Andreas.Barthel@uni-duesseldorf.de
authors.forename: A
authors.initials: A
authors.lastname: Barthel
authors.forename: S
authors.initials: S
authors.lastname: Herzig
authors.forename: H-W
authors.initials: HW
authors.lastname: Müller
authors.forename: J
authors.initials: J
authors.lastname: Harborth
authors.forename: S R
authors.initials: SR
authors.lastname: Bornstein
mesh_terms: D000818:Animals; D015316:Genetic Therapy / Q000639:trends; D006801:Humans; D024821:Metabolic Syndrome / Q000503:physiopathology* / Q000628:therapy*; D034741:RNA, Small Interfering / Q000627:therapeutic use*
chemical_list: D034741:RNA, Small Interfering